The majority of Th17 cells in BALF obtained from IL-9−/− or WT PCP mice expressed IL-23 receptor, which presented about 50% of the Th17 population, with no significant difference between the two groups (Figure 5A). This evidence concerns the gene IL23R and pneumocystosis.